Zkusit zdarma
Kodiak Sciences Inc.

Kodiak Sciences Inc.

KOD
Cena:
$ 36.23
-1.18 (-3.15%)
Valuace
70
Růst
0
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Why One Healthcare Fund Increased Its Kodiak Sciences Stake Amid an Eye-Popping Rally

Why One Healthcare Fund Increased Its Kodiak Sciences Stake Amid an Eye-Popping Rally

15:57 17-05-2026

This clinical-stage biotech develops innovative retinal disease therapies, with its lead candidate a...

Kodiak's Q1 Loss Wider Than Expected, Pipeline Development in Focus

Kodiak's Q1 Loss Wider Than Expected, Pipeline Development in Focus

13:41 08-05-2026

KOD posts a wider Q1 loss as research & development spending rises, while positive phase III Zenkuda...

Kodiak Sciences Announces Recent Business Highlights and First Quarter 2026 Financial Results

Kodiak Sciences Announces Recent Business Highlights and First Quarter 2026 Financial Results

16:00 07-05-2026

PALO ALTO, Calif., May 7, 2026 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported re...

Kodiak Sciences to Present Pipeline Advances and KSI-101 Clinical Data, Including Results from a MESI Cohort in a Tertiary Care Uveitis Practice, at Upcoming Scientific Conferences

Kodiak Sciences to Present Pipeline Advances and KSI-101 Clinical Data, Including Results from a MESI Cohort in a Tertiary Care Uveitis Practice, at Upcoming Scientific Conferences

0:23 01-05-2026

Clinical results of KSI-101 in macular edema secondary to inflammation (MESI) from a tertiary care u...

Kodiak Sciences (KOD) Up 2% Since Last Earnings Report: Can It Continue?

Kodiak Sciences (KOD) Up 2% Since Last Earnings Report: Can It Continue?

12:31 30-04-2026

Kodiak Sciences (KOD) reported earnings 30 days ago. What's next for the stock?...

Kodiak Q4 Loss Wider Than Expected, Pipeline Development in Focus

Kodiak Q4 Loss Wider Than Expected, Pipeline Development in Focus

13:46 01-04-2026

KOD posts wider Q4 loss. However, its pipeline advances, with strong phase III data for Zenkuda driv...

Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results

Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results

16:45 31-03-2026

PALO ALTO, Calif., March 31, 2026 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported...

Kodiak Sciences: Road To $120

Kodiak Sciences: Road To $120

10:00 30-03-2026

Kodiak Sciences' stock (NASDAQ: KOD) experienced a substantial 62% surge last week, elevating the st...

Kodiak Sciences (NASDAQ:KOD) Reaches New 52-Week High – Time to Buy?

Kodiak Sciences (NASDAQ:KOD) Reaches New 52-Week High – Time to Buy?

4:23 28-03-2026

Kodiak Sciences Inc. (NASDAQ: KOD - Get Free Report) shares hit a new 52-week high during trading on...

KOD Stock Soars on Promising Phase III Data for Eye Disease Candidate

KOD Stock Soars on Promising Phase III Data for Eye Disease Candidate

13:11 27-03-2026

Kodiak Sciences rallies 75% as phase III GLOW2 data show Zenkuda's strong efficacy, safety and risk ...

Kodiak Sciences Stock Is Surging Friday: What's Driving The Action?

Kodiak Sciences Stock Is Surging Friday: What's Driving The Action?

10:40 27-03-2026

Investors appear to be responding to both the strength of the data and the possibility of a faster p...

Kodiak Sciences shares surge after eye drug succeeds in late-stage study

Kodiak Sciences shares surge after eye drug succeeds in late-stage study

8:12 26-03-2026

Shares of drug developer Kodiak Sciences jumped 52% before the bell on Thursday after its experiment...

Investment Firm Doubles Down on Biotech Stock, Adds 386,000 Shares, According to Recent SEC Filing

Investment Firm Doubles Down on Biotech Stock, Adds 386,000 Shares, According to Recent SEC Filing

9:46 09-03-2026

This clinical-stage biotech targets retinal diseases with late-stage drug candidates and a focused p...

Kodiak Sciences Inc. (NASDAQ:KOD) Receives $28.29 Consensus Target Price from Brokerages

Kodiak Sciences Inc. (NASDAQ:KOD) Receives $28.29 Consensus Target Price from Brokerages

2:52 05-03-2026

Kodiak Sciences Inc. (NASDAQ: KOD - Get Free Report) has received an average recommendation of "Mode...

Kodiak Sciences Stock Up 480% as One Fund Discloses $53 Million Buy

Kodiak Sciences Stock Up 480% as One Fund Discloses $53 Million Buy

13:20 23-02-2026

Baker Bros. Advisors increased its Kodiak Sciences stake by 2,608,696 shares; the estimated trade si...

Kodiak Sciences (NASDAQ:KOD) Shares Down 5.9% – What’s Next?

Kodiak Sciences (NASDAQ:KOD) Shares Down 5.9% – What’s Next?

4:36 22-02-2026

Kodiak Sciences Inc. (NASDAQ: KOD - Get Free Report)'s stock price dropped 5.9% on Friday. The stock...

Inside a $58 Million Bet on Kodiak Amid $184 Million Offering and Phase 3 Readouts Ahead

Inside a $58 Million Bet on Kodiak Amid $184 Million Offering and Phase 3 Readouts Ahead

17:14 19-02-2026

Connecticut-based Braidwell bought 2,072,788 shares in Kodiak Sciences in the fourth quarter. The qu...

KOD Stock Up 24% in 3 Months: Here's What You Need to Know

KOD Stock Up 24% in 3 Months: Here's What You Need to Know

12:35 06-02-2026

Kodiak Sciences' shares jump 24% in three months as late-stage retinal programs advance and fresh fu...

Final APEX Phase 1b Clinical Results for Kodiak's KSI-101 in Macular Edema Secondary to Inflammation to be Presented at Angiogenesis 2026

Final APEX Phase 1b Clinical Results for Kodiak's KSI-101 in Macular Edema Secondary to Inflammation to be Presented at Angiogenesis 2026

7:00 04-02-2026

PALO ALTO, Calif., Feb. 4, 2026 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial...

Kodiak Sciences Inc. (NASDAQ:KOD) Receives $26.57 Average PT from Brokerages

Kodiak Sciences Inc. (NASDAQ:KOD) Receives $26.57 Average PT from Brokerages

3:52 14-01-2026

Shares of Kodiak Sciences Inc. (NASDAQ: KOD - Get Free Report) have been given a consensus rating of...

close

FINAL APEX PHASE 1B CLINICAL RESULTS FOR KODIAK'S KSI-101 IN MACULAR EDEMA SECONDARY TO INFLAMMATION TO BE PRESENTED AT ANGIOGENESIS 2026

04-02-2026
PALO ALTO, CALIF., FEB. 4, 2026 /PRNEWSWIRE/ -- KODIAK SCIENCES INC. (NASDAQ: KOD), A PRECOMMERCIAL...
Více zde

KODIAK SCIENCES TO PRESENT AT 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

07-01-2026
PALO ALTO, CALIF., JAN. 7, 2026 /PRNEWSWIRE/ -- KODIAK SCIENCES INC. (NASDAQ: KOD), A PRECOMMERCIAL...
Více zde

KODIAK SCIENCES ANNOUNCES CLOSING OF $184 MILLION PUBLIC OFFERING OF COMMON STOCK INCLUDING FULL EXERCISE OF UNDERWRITERS' OPTION TO PURCHASE ADDITIONAL SHARES

18-12-2025
PALO ALTO, CALIF. , DEC. 18, 2025 /PRNEWSWIRE/ -- KODIAK SCIENCES INC. (NASDAQ: KOD), A PRECOMMERCIA...
Více zde

KODIAK SCIENCES ANNOUNCES PRICING OF UPSIZED PUBLIC OFFERING OF COMMON STOCK

16-12-2025
PALO ALTO, CALIF. , DEC. 16, 2025 /PRNEWSWIRE/ -- KODIAK SCIENCES INC. (NASDAQ: KOD), A PRECOMMERCIA...
Více zde

KODIAK SCIENCES ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

15-12-2025
PALO ALTO, CALIF. , DEC. 15, 2025 /PRNEWSWIRE/ -- KODIAK SCIENCES INC. (NASDAQ: KOD), A PRECOMMERCIA...
Více zde

KODIAK SCIENCES ANNOUNCES RECENT BUSINESS HIGHLIGHTS AND THIRD QUARTER 2025 FINANCIAL RESULTS

13-11-2025
PALO ALTO, CALIF. , NOV. 13, 2025 /PRNEWSWIRE/ -- KODIAK SCIENCES INC. (NASDAQ: KOD), TODAY REPORTED...
Více zde

KODIAK SCIENCES TO PRESENT AT UPCOMING INVESTOR CONFERENCES

12-11-2025
PALO ALTO, CALIF. , NOV. 12, 2025 /PRNEWSWIRE/ -- KODIAK SCIENCES INC. (NASDAQ: KOD), A PRECOMMERCIA...
Více zde

FOLLOW-UP DATA FOR KODIAK'S KSI-101 FROM THE APEX STUDY SHOWED CONTINUED STRENGTHENING OF CLINICAL EFFECT (≥90% OF PATIENTS ACHIEVING ABSENCE OF INTRARETINAL AND SUBRETINAL FLUID) THROUGH WEEK 20 IN MACULAR EDEMA SECONDARY TO INFLAMMATION (MESI)

05-11-2025
MEANINGFUL VISION GAINS ARE RAPIDLY ACHIEVED AS EARLY AS WEEK 4 AND SHOWED CONTINUED IMPROVEMENT IN ...
Více zde

NEW DATA FOR KODIAK'S KSI-101 FROM THE APEX STUDY REINFORCE ITS CLINICALLY MEANINGFUL VISION GAINS AND RAPID RETINAL DRYING IN MACULAR EDEMA SECONDARY TO INFLAMMATION (MESI)

15-09-2025
MEANINGFUL VISION GAINS ARE RAPIDLY ACHIEVED AS EARLY AS WEEK 4 AND MORE THAN HALF OF PATIENTS IN TH...
Více zde

KODIAK SCIENCES TO PARTICIPATE IN UPCOMING SCIENTIFIC CONFERENCES HIGHLIGHTING KSI-101 IN PATIENTS WITH MACULAR EDEMA SECONDARY TO INFLAMMATION (MESI)

02-09-2025
PALO ALTO, CALIF. , SEPT. 2, 2025 /PRNEWSWIRE/ -- KODIAK SCIENCES INC. (NASDAQ: KOD), A PRECOMMERCI...
Více zde

HARBOUR BIOMED REPORTS 2025 INTERIM RESULTS

27-08-2025
CAMBRIDGE, MASS., ROTTERDAM, NETHERLANDS AND SHANGHAI , AUG. 27, 2025 /PRNEWSWIRE/ -- HARBOUR BIOME...
Více zde

KODIAK SCIENCES TO PRESENT AT AMERICAN CHEMICAL SOCIETY FALL 2025

19-08-2025
PALO ALTO, CALIF. , AUG. 19, 2025 /PRNEWSWIRE/ -- KODIAK SCIENCES INC. (NASDAQ: KOD), A PRECOMMERCIA...
Více zde

KODIAK SCIENCES ANNOUNCES RECENT BUSINESS HIGHLIGHTS AND SECOND QUARTER 2025 FINANCIAL RESULTS

13-08-2025
PALO ALTO, CALIF. , AUG. 13, 2025 /PRNEWSWIRE/ -- KODIAK SCIENCES INC. (NASDAQ: KOD), TODAY REPORTED...
Více zde

KODIAK SCIENCES TO HOST INVESTOR R&D DAY ON JULY 16, 2025

10-07-2025
PALO ALTO, CALIF.  , JULY 10, 2025 /PRNEWSWIRE/ -- KODIAK SCIENCES INC. (NASDAQ: KOD), A PRECOMMERC...
Více zde

KODIAK SCIENCES TO PRESENT KSI-101 HIGHLIGHTS AT 2025 CONGRESS OF THE INTERNATIONAL OCULAR INFLAMMATION SOCIETY

25-06-2025
PALO ALTO, CALIF. , JUNE 25, 2025 /PRNEWSWIRE/ -- KODIAK SCIENCES INC. (NASDAQ: KOD), A BIOPHARMACEU...
Více zde

KODIAK SCIENCES TO PRESENT AT 2025 JEFFERIES GLOBAL HEALTHCARE CONFERENCE

29-05-2025
PALO ALTO, CALIF. , MAY 29, 2025 /PRNEWSWIRE/ -- KODIAK SCIENCES INC. (NASDAQ: KOD), A BIOPHARMACEUT...
Více zde

KODIAK SCIENCES ANNOUNCES RECENT BUSINESS HIGHLIGHTS AND FIRST QUARTER 2025 FINANCIAL RESULTS

14-05-2025
PALO ALTO, CALIF. , MAY 14, 2025 /PRNEWSWIRE/ -- KODIAK SCIENCES INC. (NASDAQ: KOD), TODAY REPORTED ...
Více zde

KODIAK SCIENCES DATA AT ARVO 2025 HIGHLIGHT POWER AND VERSATILITY OF ABC PLATFORM IN ADDRESSING COMPLEX MULTIFACTORIAL OCULAR DISEASES

01-05-2025
PALO ALTO, CALIF. , MAY 1, 2025 /PRNEWSWIRE/ -- KODIAK SCIENCES INC. (NASDAQ: KOD), A BIOPHARMACEUT...
Více zde

KODIAK SCIENCES ANNOUNCES RECENT BUSINESS HIGHLIGHTS AND FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS

27-03-2025
PALO ALTO, CALIF. , MARCH 27, 2025 /PRNEWSWIRE/ -- KODIAK SCIENCES INC. (NASDAQ: KOD), TODAY REPORTE...
Více zde

KODIAK SCIENCES COMPLETES ENROLLMENT IN SECOND REGISTRATIONAL TRIAL OF TARCOCIMAB IN PATIENTS WITH DIABETIC RETINOPATHY

10-03-2025
TOPLINE CLINICAL DATA OF THE CONFIRMATORY REGISTRATIONAL STUDY GLOW2 EXPECTED IN 1Q 2026. GLOW2 STUD...
Více zde

KODIAK SCIENCES TO PRESENT AT GLAUCOMA 360 NEW HORIZONS FORUM 2025

04-02-2025
PALO ALTO, CALIF. , FEB. 4, 2025 /PRNEWSWIRE/ -- KODIAK SCIENCES INC. (NASDAQ: KOD), A BIOPHARMACEU...
Více zde

KODIAK SCIENCES TO PRESENT AT 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

07-01-2025
PALO ALTO, CALIF. , JAN. 7, 2025 /PRNEWSWIRE/ -- KODIAK SCIENCES INC. (NASDAQ: KOD), A BIOPHARMACEUT...
Více zde

KODIAK SCIENCES ANNOUNCES RECENT BUSINESS HIGHLIGHTS AND THIRD QUARTER 2024 FINANCIAL RESULTS

14-11-2024
PALO ALTO, CALIF. , NOV. 14, 2024 /PRNEWSWIRE/ -- KODIAK SCIENCES INC. (NASDAQ: KOD), TODAY REPORTED...
Více zde

KODIAK SCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

11-11-2024
PALO ALTO, CALIF. , NOV. 11, 2024 /PRNEWSWIRE/ -- KODIAK SCIENCES INC. (NASDAQ: KOD), A BIOPHARMACEU...
Více zde

KODIAK SCIENCES TO PRESENT AT INNOVATE RETINA 2024

14-10-2024
PALO ALTO, CALIF. , OCT. 14, 2024 /PRNEWSWIRE/ -- KODIAK SCIENCES INC. (NASDAQ: KOD), A BIOPHARMACEU...
Více zde

KODIAK SCIENCES TO HOST INVESTOR R&D DAY TODAY AT 10:30AM EASTERN TIME

23-09-2024
NEW YORK , SEPT. 23, 2024 /PRNEWSWIRE/ -- KODIAK SCIENCES INC. (NASDAQ: KOD), WILL HOST ITS INVESTOR...
Více zde

KODIAK SCIENCES TO HOST INVESTOR R&D DAY ON SEPTEMBER 23, 2024 IN NEW YORK CITY

17-09-2024
PALO ALTO, CALIF. , SEPT. 17, 2024 /PRNEWSWIRE/ -- KODIAK SCIENCES INC. (NASDAQ: KOD), A BIOPHARMACE...
Více zde

KODIAK SCIENCES ANNOUNCES RECENT BUSINESS HIGHLIGHTS AND SECOND QUARTER 2024 FINANCIAL RESULTS

14-08-2024
PALO ALTO, CALIF. , AUG. 14, 2024 /PRNEWSWIRE/ -- KODIAK SCIENCES INC. (NASDAQ: KOD), TODAY REPORTED...
Více zde

KODIAK SCIENCES TO PRESENT AT UPCOMING INVESTOR AND CLINICAL CONFERENCES

29-05-2024
PALO ALTO, CALIF. , MAY 29, 2024 /PRNEWSWIRE/ -- KODIAK SCIENCES INC. (NASDAQ: KOD), A BIOPHARMACEUT...
Více zde

KODIAK SCIENCES ANNOUNCES RECENT BUSINESS HIGHLIGHTS AND FIRST QUARTER 2024 FINANCIAL RESULTS

15-05-2024
PALO ALTO, CALIF. , MAY 15, 2024 /PRNEWSWIRE/ -- KODIAK SCIENCES INC. (NASDAQ: KOD), TODAY REPORTED...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2025-12-18 00:00:008-KStáhnout
2025-11-13 00:00:008-KStáhnout
2025-11-13 00:00:0010-QStáhnout
2025-08-13 01:00:008-KStáhnout
2025-08-13 01:00:0010-QStáhnout
2025-08-13 00:00:008-KStáhnout
2025-08-13 00:00:0010-QStáhnout
2025-06-03 01:00:008-KStáhnout
2025-06-03 00:00:008-KStáhnout
2025-05-14 01:00:008-KStáhnout
2025-05-14 01:00:0010-QStáhnout
2025-05-14 00:00:008-KStáhnout
2025-05-14 00:00:0010-QStáhnout
2025-03-27 00:00:008-KStáhnout
2025-03-27 00:00:0010-KStáhnout
2025-03-26 23:00:008-KStáhnout
2025-03-26 23:00:0010-KStáhnout
2024-11-14 00:00:008-KStáhnout
2024-11-14 00:00:0010-QStáhnout
2024-11-13 23:00:008-KStáhnout
2024-11-13 23:00:0010-QStáhnout
2024-08-14 01:00:008-KStáhnout
2024-08-14 01:00:0010-QStáhnout
2024-08-14 00:00:008-KStáhnout
2024-08-14 00:00:0010-QStáhnout
2024-06-06 01:00:008-KStáhnout
2024-06-06 00:00:008-KStáhnout
2024-05-15 01:00:008-KStáhnout
2024-05-15 01:00:0010-QStáhnout
2024-05-15 00:00:008-KStáhnout
2024-05-15 00:00:0010-QStáhnout
2024-03-28 00:00:008-KStáhnout
2024-03-28 00:00:0010-KStáhnout
2024-03-27 23:00:008-KStáhnout
2023-11-14 00:00:008-KStáhnout
2023-11-14 00:00:0010-QStáhnout
2023-11-13 23:00:008-KStáhnout
2023-11-13 23:00:0010-QStáhnout
2023-11-06 00:00:008-KStáhnout
2023-11-05 23:00:008-KStáhnout
2023-08-17 01:00:008-KStáhnout
2023-08-17 00:00:008-KStáhnout
2023-08-14 01:00:008-KStáhnout
2023-08-14 01:00:0010-QStáhnout
2023-08-14 00:00:008-KStáhnout
2023-08-14 00:00:0010-QStáhnout
2023-07-24 01:00:008-KStáhnout
2023-07-24 00:00:008-KStáhnout
2023-06-07 01:00:008-KStáhnout
2023-06-07 00:00:008-KStáhnout
2023-05-15 01:00:008-KStáhnout
2023-05-15 01:00:0010-QStáhnout
2023-05-15 00:00:008-KStáhnout
2023-05-15 00:00:0010-QStáhnout
2023-03-28 01:00:008-KStáhnout
2023-03-28 01:00:0010-KStáhnout
2023-03-28 00:00:008-KStáhnout
2023-03-28 00:00:0010-KStáhnout
2022-11-09 00:00:008-KStáhnout
2022-11-09 00:00:0010-QStáhnout
2022-11-08 23:00:008-KStáhnout
2022-11-08 23:00:0010-QStáhnout
2022-08-09 01:00:008-KStáhnout
2022-08-09 01:00:0010-QStáhnout
2022-08-09 00:00:008-KStáhnout
2022-08-09 00:00:0010-QStáhnout
2022-08-08 01:00:008-KStáhnout
2022-08-08 00:00:008-KStáhnout
2022-06-08 01:00:008-KStáhnout
2022-06-08 00:00:008-KStáhnout
2022-05-10 01:00:008-KStáhnout
2022-05-10 01:00:0010-QStáhnout
2022-05-10 00:00:008-KStáhnout
2022-05-10 00:00:0010-QStáhnout
2022-03-01 00:00:008-KStáhnout
2022-03-01 00:00:0010-KStáhnout
2022-02-28 23:00:008-KStáhnout
2022-02-28 23:00:0010-KStáhnout
2022-02-23 00:00:008-KStáhnout
2022-02-22 23:00:008-KStáhnout
2021-11-09 00:00:008-KStáhnout
2021-11-09 00:00:0010-QStáhnout
2021-11-08 23:00:008-KStáhnout
2021-11-08 23:00:0010-QStáhnout
2021-10-15 01:00:008-KStáhnout
2021-10-15 00:00:008-KStáhnout
2021-09-01 01:00:008-KStáhnout
2021-09-01 00:00:008-KStáhnout
2021-08-09 01:00:008-KStáhnout
2021-08-09 01:00:0010-QStáhnout
2021-08-09 00:00:008-KStáhnout
2021-08-09 00:00:0010-QStáhnout
2021-07-23 01:00:008-KStáhnout
2021-07-23 00:00:008-KStáhnout
2021-06-08 01:00:008-KStáhnout
2021-06-08 00:00:008-KStáhnout
2021-05-10 01:00:008-KStáhnout
2021-05-10 01:00:0010-QStáhnout
2021-05-10 00:00:008-KStáhnout
2021-05-10 00:00:0010-QStáhnout
2021-03-01 00:00:008-KStáhnout
2021-03-01 00:00:0010-KStáhnout
2021-02-28 23:00:008-KStáhnout
2021-02-28 23:00:0010-KStáhnout
2020-11-18 00:00:008-KStáhnout
2020-11-17 23:00:008-KStáhnout
2020-11-09 00:00:008-KStáhnout
2020-11-09 00:00:0010-QStáhnout
2020-11-08 23:00:008-KStáhnout
2020-11-08 23:00:0010-QStáhnout
2020-08-20 01:00:008-KStáhnout
2020-08-20 00:00:008-KStáhnout
2020-08-10 01:00:008-KStáhnout
2020-08-10 01:00:0010-QStáhnout
2020-08-10 00:00:008-KStáhnout
2020-08-10 00:00:0010-QStáhnout
2020-06-25 01:00:008-KStáhnout
2020-06-25 00:00:008-KStáhnout
2020-06-09 01:00:008-KStáhnout
2020-06-09 00:00:008-KStáhnout
2020-05-11 01:00:008-KStáhnout
2020-05-11 01:00:0010-QStáhnout
2020-05-11 00:00:008-KStáhnout
2020-05-11 00:00:0010-QStáhnout
2020-04-03 01:00:008-KStáhnout
2020-04-03 00:00:008-KStáhnout
2020-03-16 00:00:008-KStáhnout
2020-03-16 00:00:0010-KStáhnout
2020-03-15 23:00:008-KStáhnout
2020-03-15 23:00:0010-KStáhnout
2019-12-19 00:00:008-KStáhnout
2019-12-18 23:00:008-KStáhnout
2019-12-04 00:00:008-KStáhnout
2019-12-03 23:00:008-KStáhnout
2019-12-02 00:00:008-KStáhnout
2019-12-01 23:00:008-KStáhnout
2019-11-20 00:00:008-KStáhnout
2019-11-19 23:00:008-KStáhnout
2019-11-12 00:00:008-KStáhnout
2019-11-12 00:00:0010-QStáhnout
2019-11-11 23:00:008-KStáhnout
2019-11-11 23:00:0010-QStáhnout
2019-10-15 01:00:008-KStáhnout
2019-10-15 00:00:008-KStáhnout
2019-10-10 01:00:008-KStáhnout
2019-10-10 00:00:008-KStáhnout
2019-09-12 01:00:008-KStáhnout
2019-09-12 00:00:008-KStáhnout
2019-08-14 01:00:008-KStáhnout
2019-08-14 01:00:0010-QStáhnout
2019-08-14 00:00:008-KStáhnout
2019-08-14 00:00:0010-QStáhnout
2019-07-29 01:00:008-KStáhnout
2019-07-29 00:00:008-KStáhnout
2019-06-05 01:00:008-KStáhnout
2019-06-05 00:00:008-KStáhnout
2019-05-15 01:00:008-KStáhnout
2019-05-15 01:00:0010-QStáhnout
2019-05-15 00:00:008-KStáhnout
2019-05-15 00:00:0010-QStáhnout
2019-03-28 00:00:008-KStáhnout
2019-03-27 23:00:008-KStáhnout
2019-03-27 00:00:0010-KStáhnout
2019-03-26 23:00:0010-KStáhnout
2019-02-05 00:00:008-KStáhnout
2019-02-04 23:00:008-KStáhnout
2019-01-28 00:00:008-KStáhnout
2019-01-27 23:00:008-KStáhnout
2018-11-16 00:00:008-KStáhnout
2018-11-16 00:00:0010-QStáhnout
2018-11-15 23:00:008-KStáhnout
2018-11-15 23:00:0010-QStáhnout
preloader